Artesunate Demonstrates in vitro Synergism with Several Antiviral Agents against Human Cytomegalovirus
Background Human cytomegalovirus (HCMV) infections remain a major problem in
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
E Drouot, J Piret, G Boivin - Antiviral Therapy, 2016 - europepmc.org
Background Human cytomegalovirus (HCMV) infections remain a major problem in
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus
E Drouot, J Piret, G Boivin - Antiviral therapy, 2016 - pubmed.ncbi.nlm.nih.gov
Background Human cytomegalovirus (HCMV) infections remain a major problem in
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
[PDF][PDF] Short communication Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus
E Drouot, J Piret, G Boivin - Antiviral Therapy, 2016 - scholar.archive.org
Background: Human cytomegalovirus (HCMV) infections remain a major problem in
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …
immunocompromised patients. Three antiviral agents, ganciclovir (GCV), foscarnet (FOS) …